Yubo International Biotech Ltd (YBGJ)
0.0905
-0.04
(-32.86%)
USD |
OTCM |
Nov 14, 13:05
Yubo International Biotech Total Liabilities (Quarterly): 4.150M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 4.150M |
March 31, 2024 | 3.610M |
December 31, 2023 | 3.511M |
September 30, 2023 | 3.005M |
June 30, 2023 | 3.112M |
March 31, 2023 | 2.952M |
December 31, 2022 | 2.914M |
September 30, 2022 | 4.378M |
Date | Value |
---|---|
June 30, 2022 | 5.302M |
March 31, 2022 | 5.226M |
December 31, 2021 | 4.718M |
September 30, 2021 | 4.135M |
June 30, 2021 | 3.606M |
March 31, 2021 | 2.981M |
December 31, 2020 | 1.277M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.277M
Minimum
Dec 2020
5.302M
Maximum
Jun 2022
3.658M
Average
3.606M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
Hologic Inc | 4.026B |
Nuwellis Inc | 13.02M |
Linike Medical Group Ltd | 0.5317M |
Varex Imaging Corp | 657.40M |
Quanterix Corp | 74.54M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.729M |
Shareholders Equity (Quarterly) | -2.524M |